Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

被引：320

作者：

Huh, Warner K. ^{[1
]}

Ault, Kevin A. ^{[2
]}

Chelmow, David ^{[3
]}

Davey, Diane D. ^{[4
]}

Goulart, Robert A. ^{[5
]}

Garcia, Francisco A. R. ^{[6
]}

Kinney, Walter K. ^{[7
]}

Massad, L. Stewart ^{[8
]}

Mayeaux, Edward J. ^{[9
]}

Saslow, Debbie ^{[10
]}

Schiffman, Mark ^{[11
]}

Wentzensen, Nicolas ^{[11
]}

Lawson, Herschel W. ^{[12
]}

Einstein, Mark H. ^{[13
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

[3] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA

[4] Univ Cent Florida, Orlando, FL 32816 USA

[5] New England Pathol Associates, Springfield, MA USA

[6] Pima Cty Hlth Dept, Tucson, AZ USA

[7] Kaiser Permanente, Sacramento, CA USA

[8] Washington Univ, Sch Med, St Louis, MO USA

[9] Univ S Carolina, Sch Med, Columbia, SC USA

[10] Amer Canc Soc, Atlanta, GA 30329 USA

[11] NCI, Bethesda, MD 20892 USA

[12] Amer Soc Colposcopy & Cerv Pathol, Frederick, MD USA

[13] Albert Einstein Coll Med, Bronx, NY 10467 USA

来源：

GYNECOLOGIC ONCOLOGY | 2015年 / 136卷 / 02期

关键词：

LIQUID-BASED CYTOLOGY; FOLLOW-UP; COLPOSCOPY; PREVENTION; SERVICES; WOMEN; TRIAL;

D O I：

10.1016/j.ygyno.2014.12.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In 2011, the American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology updated screening guidelines for the early detection of cervical cancer and its precursors. Recommended screening strategies were cytology and cotesting (cytology in combination with hrHPV testing). These guidelines also addressed the use of hrHPV testing alone as a primary screening approach, which was not recommended for use at that time. There is now a growing body of evidence for screening with primary hrHPV testing, including a prospective US-based registration study. Thirteen experts including representatives from the Society of Gynecologic Oncology, American Society for Colposcopy and Cervical Pathology, American College of Obstetricians and Gynecologists, American Cancer Society, American Society of Cytopathology, College of American Pathologists, and the American Society for Clinical Pathology, convened to provide interim guidance for primary hrHPV screening. This guidance panel was specifically triggered by an application to the FDA for a currently marketed HPV test to be labeled for the additional indication of primary cervical cancer screening. Guidance was based on literature review and review of data from the FDA registration study, supplemented by expert opinion. This document aims to provide information for healthcare providers who are interested in primary hrHPV testing and an overview of the potential advantages and disadvantages of this strategy for screening as well as to highlight areas in need of further investigation. (C) 2014 the Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology. Published by Elsevier Inc. All rights reserved.

引用

页码：178 / 182

页数：5

共 24 条

[11] The HPV test has similar sensitivity but more overdiagnosis than the Pap testA randomised health services study on cervical cancer screening in Finland [J].